GlassScriptPhysician profile
Carol P Magee
NPI 1326061631
$1,413.72
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $183 · 2022: $14.38.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $238.84 | 2019-2020 | |
| Novo Nordisk INC | $206.88 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $176.00 | 2019-2020 | |
| Glaxosmithkline, LLC. | $174.89 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $164.84 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.96 | 2019-2020 | |
| Tei Medical INC. | $47.00 | 2019 | |
| Amgen INC. | $44.81 | 2019 | |
| Astellas Pharma US INC | $35.21 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.47 | 2019 | |
| Merck Sharp & Dohme LLC | $27.62 | 2019-2020 | |
| Pfizer INC. | $24.85 | 2019 | |
| Allergan, INC. | $24.55 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.78 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.67 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $16.33 | 2019 | |
| Medtronic, INC. | $14.38 | 2022 | |
| Amarin Pharma, INC. | $13.85 | 2019 | |
| Sunovion Pharmaceuticals INC. | $13.48 | 2019 | |
| Corcept Therapeutics | $12.69 | 2019 | |
| Genentech USA, INC. | $11.62 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.